Volume | 213,402 |
|
|||||
News | - | ||||||
Day High | 26.39 | Low High |
|||||
Day Low | 25.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
26.39 | 25.35 | 26.39 | 26.11 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,684 | 213,402 | $ 25.74 | $ 5,493,608 | - | 13.72 - 33.34 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:43:17 | 8 | $ 25.89 | USD |
Protagonist Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.51B | 58.27M | - | 60M | -78.96M | -1.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Protagonist Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 28.22 | 28.54 | 25.35 | 27.12 | 570,068 | -2.33 | -8.26% |
1 Month | 28.82 | 29.73 | 25.35 | 27.99 | 549,709 | -2.93 | -10.17% |
3 Months | 25.25 | 33.34 | 24.21 | 28.06 | 702,844 | 0.64 | 2.53% |
6 Months | 15.66 | 33.34 | 13.72 | 23.49 | 717,873 | 10.23 | 65.33% |
1 Year | 19.02 | 33.34 | 13.72 | 23.02 | 823,836 | 6.87 | 36.12% |
3 Years | 26.27 | 50.54 | 6.91 | 21.03 | 981,229 | -0.38 | -1.45% |
5 Years | 10.50 | 50.54 | 4.47 | 19.75 | 760,949 | 15.39 | 146.57% |
Protagonist Therapeutics Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. |